Views & Analysis Pharma websites: a great time to get closer to patients Wary US consumers present opportunities for pharma to become trusted resources for health information.
Views & Analysis The convergence of healthcare: when digital and medical coll... How traditional and digital approaches are being brought ever closer together in healthcare.
News NICE backs first targeted therapy for ALK+ lung cancer Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.